Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $9,913 | 698 | 99.5% |
| Education | $48.17 | 5 | 0.5% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| ABBVIE INC. | $995.13 | 65 | $0 (2024) |
| AstraZeneca Pharmaceuticals LP | $945.24 | 48 | $0 (2024) |
| Novo Nordisk Inc | $834.59 | 66 | $0 (2024) |
| GlaxoSmithKline, LLC. | $831.27 | 55 | $0 (2024) |
| PFIZER INC. | $735.54 | 54 | $0 (2024) |
| Lilly USA, LLC | $642.99 | 53 | $0 (2024) |
| Amgen Inc. | $626.12 | 41 | $0 (2024) |
| Merck Sharp & Dohme LLC | $533.95 | 47 | $0 (2024) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $474.16 | 33 | $0 (2024) |
| Allergan, Inc. | $426.40 | 32 | $0 (2020) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $1,214 | 74 | ABBVIE INC. ($311.93) |
| 2023 | $1,517 | 94 | ABBVIE INC. ($371.99) |
| 2022 | $1,450 | 91 | GlaxoSmithKline, LLC. ($214.41) |
| 2021 | $1,331 | 96 | GlaxoSmithKline, LLC. ($251.72) |
| 2020 | $709.98 | 52 | Allergan, Inc. ($182.83) |
| 2019 | $1,097 | 81 | Amgen Inc. ($198.88) |
| 2018 | $1,375 | 111 | Amgen Inc. ($201.76) |
| 2017 | $1,267 | 104 | PFIZER INC. ($152.58) |
All Payment Transactions
703 individual payment records from CMS Open Payments — Page 1 of 29
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/30/2024 | Seqirus USA Inc | Fluad (Biological), Flucelvax | Food and Beverage | In-kind items and services | $13.68 | General |
| Category: Vaccines | ||||||
| 12/10/2024 | Vanda Pharmaceuticals Inc. | FANAPT (Drug) | Food and Beverage | In-kind items and services | $21.46 | General |
| Category: SCHIZOPHRENIA | ||||||
| 12/05/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | OFEV (Drug) | Food and Beverage | In-kind items and services | $22.62 | General |
| Category: RESPIRATORY | ||||||
| 12/03/2024 | Novo Nordisk Inc | Rybelsus (Drug), Ozempic | Food and Beverage | In-kind items and services | $5.17 | General |
| Category: Diabetes | ||||||
| 12/03/2024 | Novo Nordisk Inc | Rybelsus (Drug), Ozempic | Food and Beverage | In-kind items and services | $1.02 | General |
| Category: Diabetes | ||||||
| 11/21/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $6.31 | General |
| Category: Diabetes | ||||||
| 11/19/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $30.58 | General |
| Category: NEUROSCIENCE | ||||||
| 11/18/2024 | Phadia US Inc. | ImmunoCAP (Device) | Food and Beverage | Cash or cash equivalent | $21.31 | General |
| Category: Allergy/Immunology | ||||||
| 11/15/2024 | GlaxoSmithKline, LLC. | SHINGRIX (Biological), AREXVY | Food and Beverage | In-kind items and services | $16.88 | General |
| Category: VACCINES | ||||||
| 11/12/2024 | Novo Nordisk Inc | Saxenda (Drug), Wegovy | Food and Beverage | In-kind items and services | $12.35 | General |
| Category: Obesity | ||||||
| 11/11/2024 | Exact Sciences Corporation | Cologuard Collection Kit (Device) | Food and Beverage | In-kind items and services | $21.57 | General |
| Category: Oncology | ||||||
| 11/06/2024 | Merck Sharp & Dohme LLC | GARDASIL (Biological), CAPVAXIVE, GARDASIL 9 | Food and Beverage | In-kind items and services | $22.17 | General |
| Category: VACCINE | ||||||
| 11/04/2024 | Kowa Pharmaceuticals America, Inc. | ZORYVE (Drug) | Food and Beverage | In-kind items and services | $16.82 | General |
| Category: DERMATOLOGY | ||||||
| 10/29/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $5.67 | General |
| Category: Diabetes | ||||||
| 10/28/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $29.15 | General |
| Category: NEUROSCIENCE | ||||||
| 10/03/2024 | ABBVIE INC. | QULIPTA (Drug), UBRELVY | Food and Beverage | In-kind items and services | $7.79 | General |
| Category: NEUROSCIENCE | ||||||
| 09/25/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $6.03 | General |
| Category: Diabetes | ||||||
| 09/18/2024 | Novo Nordisk Inc | Saxenda (Drug), Wegovy | Food and Beverage | In-kind items and services | $19.21 | General |
| Category: Obesity | ||||||
| 09/03/2024 | E.R. Squibb & Sons, L.L.C. | CAMZYOS (Drug) | Food and Beverage | Cash or cash equivalent | $15.74 | General |
| Category: Cardiovascular | ||||||
| 08/29/2024 | Phathom Pharmaceuticals, Inc. | VOQUEZNA (Drug) | Food and Beverage | In-kind items and services | $13.36 | General |
| Category: GASTROENTEROLOGY | ||||||
| 08/28/2024 | Lilly USA, LLC | MOUNJARO (Drug), ZEPBOUND | Food and Beverage | In-kind items and services | $19.58 | General |
| Category: Diabetes | ||||||
| 08/22/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $6.93 | General |
| Category: Diabetes | ||||||
| 08/22/2024 | Novo Nordisk Inc | Rybelsus (Drug), Ozempic | Food and Beverage | In-kind items and services | $0.22 | General |
| Category: Diabetes | ||||||
| 08/19/2024 | Exact Sciences Corporation | Cologuard Collection Kit (Device) | Food and Beverage | In-kind items and services | $14.57 | General |
| Category: Oncology | ||||||
| 08/15/2024 | AstraZeneca Pharmaceuticals LP | — | Food and Beverage | In-kind items and services | $16.12 | General |
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 34 | 2,547 | 4,137 | $294,374 | $157,899 |
| 2022 | 38 | 2,683 | 4,191 | $292,551 | $159,524 |
| 2021 | 36 | 2,445 | 4,078 | $281,000 | $147,308 |
| 2020 | 38 | 2,540 | 4,039 | $265,159 | $121,568 |
All Medicare Procedures & Services
146 procedure records from CMS Medicare Utilization — Page 1 of 6
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 321 | 575 | $54,050 | $32,308 | 59.8% |
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 174 | 330 | $28,710 | $19,561 | 68.1% |
| 99490 | Chronic care management services, first 20 minutes of clinical staff time directed by health care professional, per calendar month | Office | 2023 | 53 | 430 | $26,363 | $17,718 | 67.2% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2023 | 144 | 144 | $21,600 | $17,379 | 80.5% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 145 | 210 | $31,290 | $16,410 | 52.4% |
| 99222 | Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes | Facility | 2023 | 95 | 106 | $21,306 | $9,903 | 46.5% |
| 99238 | Hospital discharge day management, 30 minutes or less | Facility | 2023 | 109 | 113 | $12,430 | $6,763 | 54.4% |
| 90694 | Influenza vaccine, quadrivalent inactivated, 0.5 ml dosage | Office | 2023 | 64 | 64 | $5,440 | $4,776 | 87.8% |
| 99308 | Subsequent nursing facility care with straightforward level of medical decision making, per day, if using time, at least 15 minutes | Office | 2023 | 43 | 68 | $5,576 | $3,789 | 68.0% |
| 99495 | Transitional care management services for problem of at least moderate complexity | Office | 2023 | 16 | 18 | $3,924 | $2,727 | 69.5% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2023 | 199 | 322 | $4,830 | $2,688 | 55.7% |
| 80061 | Blood test, lipids (cholesterol and triglycerides) | Office | 2023 | 147 | 195 | $10,725 | $2,519 | 23.5% |
| 0241U | Respiratory infectious agent detection by rna for severe acute respiratory syndrome coronavirus 2 (covid 19), influenza a, influenza b, and respiratory syncytial virus, upper respiratory specimen, each reported as detected or not detected | Office | 2023 | 17 | 18 | $3,600 | $2,516 | 69.9% |
| G0402 | Initial preventive physical examination; face-to-face visit, services limited to new beneficiary during the first 12 months of medicare enrollment | Office | 2023 | 16 | 16 | $3,200 | $2,487 | 77.7% |
| G0008 | Administration of influenza virus vaccine | Office | 2023 | 65 | 65 | $2,275 | $1,884 | 82.8% |
| 85025 | Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count | Office | 2023 | 170 | 241 | $6,025 | $1,826 | 30.3% |
| 80053 | Blood test, comprehensive group of blood chemicals | Office | 2023 | 141 | 176 | $9,680 | $1,811 | 18.7% |
| J0702 | Injection, betamethasone acetate 3 mg and betamethasone sodium phosphate 3 mg | Office | 2023 | 133 | 391 | $6,647 | $1,641 | 24.7% |
| 99233 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes | Facility | 2023 | 11 | 15 | $1,875 | $1,367 | 72.9% |
| 84443 | Blood test, thyroid stimulating hormone (tsh) | Office | 2023 | 49 | 70 | $5,250 | $1,152 | 21.9% |
| 71046 | X-ray of chest, 2 views | Office | 2023 | 43 | 50 | $4,500 | $1,152 | 25.6% |
| 87426 | Detection test by immunoassay technique for severe acute respiratory syndrome coronavirus | Office | 2023 | 23 | 27 | $2,700 | $876.35 | 32.5% |
| 83036 | Hemoglobin a1c level | Office | 2023 | 58 | 81 | $5,265 | $761.60 | 14.5% |
| 87804 | Detection test by immunoassay with direct visual observation for influenza virus | Office | 2023 | 22 | 46 | $2,162 | $692.49 | 32.0% |
| G0103 | Prostate cancer screening; prostate specific antigen test (psa) | Office | 2023 | 34 | 34 | $2,210 | $643.28 | 29.1% |
About Dr. Kyle Guidry, M.D
Dr. Kyle Guidry, M.D is a Family Medicine healthcare provider based in Thibodaux, Louisiana. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 08/24/2005. The National Provider Identifier (NPI) number assigned to this provider is 1619960812.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Kyle Guidry, M.D has received a total of $9,961 in payments from pharmaceutical and medical device companies, with $1,214 received in 2024. These payments were reported across 703 transactions from 58 companies. The most common payment nature is "Food and Beverage" ($9,913).
As a Medicare-enrolled provider, Guidry has provided services to 10,215 Medicare beneficiaries, totaling 16,445 services with total Medicare billing of $586,299. Data is available for 4 years (2020–2023), covering 146 distinct procedure/service records.
Practice Information
- Specialty Family Medicine
- Location Thibodaux, LA
- Active Since 08/24/2005
- Last Updated 06/29/2010
- Taxonomy Code 207Q00000X
- Entity Type Individual
- NPI Number 1619960812
Products in Payments
- VRAYLAR (Drug) $719.20
- TRELEGY ELLIPTA (Drug) $619.08
- FARXIGA (Drug) $615.11
- ELIQUIS (Drug) $395.82
- TRULICITY (Drug) $379.31
- Ozempic (Drug) $374.96
- JARDIANCE (Drug) $314.56
- Aimovig (Biological) $285.43
- Rybelsus (Drug) $257.88
- UBRELVY (Drug) $253.46
- JANUVIA (Drug) $236.73
- Livalo (Drug) $234.44
- INVOKANA (Drug) $227.35
- Prolia (Biological) $199.06
- XARELTO (Drug) $195.27
- MOUNJARO (Drug) $155.25
- XIFAXAN (Drug) $154.81
- SYMBICORT (Drug) $147.69
- CHANTIX (Drug) $147.17
- QULIPTA (Drug) $146.39
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Family Medicine Doctors in Thibodaux
Jody Plaisance, M.d, M.D
Family Medicine — Payments: $10,830
Alan Fortier, M.d, M.D
Family Medicine — Payments: $8,853
Francis Robichaux, M.d, M.D
Family Medicine — Payments: $8,656
Dr. Jenny Templet, M.d, M.D
Family Medicine — Payments: $7,593
Joshua Huval, Md, MD
Family Medicine — Payments: $6,715
John Magee, M.d, M.D
Family Medicine — Payments: $1,668